Doyle Janeen Noel insider trades
Doyle Janeen Noel has filed 3 Form 4s with the SEC that we hold, all for Janux Therapeutics, Inc. (JANX), as Chief Corp. & Bus. Dev. Ofcr. Across all of them we count 0 purchases worth $0 and 1 sale worth $56.9K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($56.9K). The largest single trade was a sale of 4,059 shares of Janux Therapeutics, Inc. worth $56.9K, dated 2026-06-02. The first filing on our record is dated 2025-06-04 and the latest 2026-06-04.
Janux Therapeutics, Inc. (JANX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-06-02 | S, sale reported on Form 4 | 4,059 | $56.9K | 2026-06-04 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2069239) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms